A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
Stopped This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.
Conditions
- Acute Ischaemic Middle Cerebral Artery Stroke
Interventions
- DRUG: Piracetam
- OTHER: Placebo
Sponsor
UCB S.A. - Pharma Sector